7hon MSN
Morgan Stanley Maintains Overweight Rating For Exelixis, Inc. (EXEL), Price Target Raised To $50
Exelixis, Inc. (NASDAQ: EXEL) is among the Renaissance Technologies Portfolio: 10 Biggest Stocks. On September 17, Morgan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback